| Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
|---|
| 02/12/2008 | US7329658 Cannabinoid receptor ligands and uses thereof |
| 02/12/2008 | US7329653 (4-cyclohexyl-phenyl)-(4H, 10H-3a,5,9-triaza-benzo[f]azulen-9-yl)-methanone; antidiuretic, anticoagulant, diabetes insipidus, nocturnal enuresis, nocturia, urinary incontinence, delay of urination, or bleeding |
| 02/12/2008 | CA2383373C Synthesis of [3,5,7]-1h-imidazo[1,5-a]imidazol-2(3h)-one compounds |
| 02/12/2008 | CA2227695C Furopyridine, thienopyridine, pyrrolopyridine and related pyrimidine, pyridazine and triazine compounds useful in controlling chemical synaptic transmission |
| 02/12/2008 | CA2174236C Superoxide dismutase and mimetics thereof |
| 02/07/2008 | WO2008016669A2 Certain chemical entities, compositions and methods |
| 02/07/2008 | WO2008016131A1 Fused heterocyclic compound |
| 02/07/2008 | WO2008016085A1 Isoindoles, compounds prepared from the same, and processes for production of both |
| 02/07/2008 | WO2008016016A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | WO2008016006A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 02/07/2008 | WO2008015516A1 Fused tricyclic heterocycles for the treatment of schizophrenia |
| 02/07/2008 | WO2008015271A1 Pyrazolopyrimidines, a process for their preparation and the use as a medicine |
| 02/07/2008 | WO2008015269A1 Substituted pyrazolopyrimidines, a process for their preparation and their use as medicine |
| 02/07/2008 | WO2008015253A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/07/2008 | WO2007150025A3 Purinone derivatives as hm74a agonists |
| 02/07/2008 | WO2007149907A3 Pyrazoloquinazolinones as parp inhibitors |
| 02/07/2008 | WO2007138472A3 Triazolopyridazine derivatives |
| 02/07/2008 | US20080033172 Mutagenic Heterocycles |
| 02/07/2008 | US20080033167 Compositions and methods for synthesizing heterocyclic therapeutic compounds |
| 02/07/2008 | US20080033164 Oxypentafluorosulfate compositions and processes for making them |
| 02/07/2008 | US20080032984 1-Ethyl-6-methyl-3-phenyl-1H-pyrinido[5,4-e]1,2,4]triazine-5,7-dione, used for lowering blood sugar, treating non-insulin dependent diabetes and insulin resistance; antidiabetic agents |
| 02/07/2008 | US20080032974 Compounds and therapeutical use thereof |
| 02/07/2008 | US20080032972 Pyridopyrazines and derivatives thereof as alk and c-Met inhibitors |
| 02/07/2008 | US20080032971 8-heteroarylpurine mnk2 inhibitors for treating metabolic disorders |
| 02/07/2008 | US20080032889 6-(2-Fluorophenyl)-Triazolopyrimidines, Method For The Production Thereof, Use Thereof For Controlling Harmful Fungi, And Agents Containing The Same |
| 02/07/2008 | US20080032442 Novel Compound and Method for Synthesizing the Same, Ink, Ink Cartridge, Recording Unit, Ink-Jet Recording Apparatus, Recording Method, Liquid Composition, Pattern Generating Method, Article, Environmental History-Detecting Method |
| 02/07/2008 | CA2659971A1 Fused heterocyclic derivative and use thereof |
| 02/07/2008 | CA2659969A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/07/2008 | CA2659687A1 Aqueous liquid preparation containing amide compound |
| 02/07/2008 | CA2659336A1 Certain 1h-imidazo[4,5-b]pyrazin-2(3h)-ones and 1h-imidazo[4,5-b]pyrazin-2-ols, compositions thereof and their use |
| 02/06/2008 | EP1884516A1 Pyrazolo[1,5-a]pyrimidines, processes, uses and compositions |
| 02/06/2008 | EP1883641A1 Phthalocyanine derivatives, process for their preparation, pharmaceutical compositions containing them, and their use |
| 02/06/2008 | EP1883640A2 Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group |
| 02/06/2008 | EP1883639A1 Preparation of famciclovir and other purine derivatives |
| 02/06/2008 | EP1883638A1 Pyrrolo [2,3-d] imidazoles for the treatment of hyperproliferative disorders |
| 02/06/2008 | EP1575958B1 Fungicidal triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing said fungicidal triazolopyrimidines |
| 02/06/2008 | EP1309596B1 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/06/2008 | CN101120001A 12位取代姆替林衍生物 12 to replace Tim triptyline derivatives |
| 02/06/2008 | CN101120000A Pyrazolopyrimidines |
| 02/06/2008 | CN101119999A 5,6-dialkyl-7-amino-azolopyrimidines, methods for the production thereof, use thereof for controlling harmful fungi, and substances containing the same |
| 02/06/2008 | CN101119998A Pyrazolo [1,5-a] pyrimidine adenosine a2a receptor antagonists |
| 02/05/2008 | US7326793 From a pyrrolidinone compound; coloring high molecular weight material |
| 02/05/2008 | US7326791 Carboxylic acid amides, the preparation thereof, and their use as pharmaceutical compositions |
| 02/05/2008 | US7326714 6,7-Dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 02/05/2008 | US7326713 Such as aurora-2 kinase or c-kit kinase; anticancer agents; based on benzo(4,5)furo(3,2-d)pyrimidine, 9-thia-1,5,7-triazafluorene, or pyrimido(5,4-b)indole rings; e.g. 6,7-dimethoxy-4-(4-(benzodioxol-5-ylmethylaminothiocarbonyl)-piperazin-1-yl)-5H-Pyrimido(5,4-b)indole |
| 02/05/2008 | US7326712 Substituted tricyclic compounds as protein kinase inhibitors |
| 02/05/2008 | US7326711 Antiproliferative agents for humans, animals |
| 02/05/2008 | US7326709 e.g. 1-((3-Phenyl-1,2,4-triazolo(3,4-a)phthalazines-6-yl)carbonyl)piperidine; high affinity to the benzodiazepine site of GABAA receptors; central nervous system (CNS) diseases such as depression, anxiety, and attention deficit disorder |
| 02/05/2008 | US7326708 Phosphoric acid salt of a dipeptidyl peptidase-IV inhibitor |
| 02/05/2008 | US7326707 Bicyclic melanocortin-specific compounds |
| 02/05/2008 | US7326705 2-amino or carbonylamino-4-carbocyclic imidazoles and thiazoles; antiischemic agents, hypotensive agents, antiarrhythmia agents; can be coadministered with other drugs |
| 02/05/2008 | US7326704 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests |
| 02/05/2008 | US7326701 Lactam compounds and pharmaceutical use thereof |
| 02/05/2008 | US7326700 Prevention of prelabor during pregnancy; central nervous system disorders, psychological disorders |
| 02/05/2008 | US7326699 4-Amino-5-phenyl-7-cyclobutyl-pyrrolo(2,3-d)pyrimidine derivatives |
| 02/05/2008 | CA2417635C Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 02/05/2008 | CA2276613C Photoactivatable nitrogen-containing bases based on .alpha.-amino ketones |
| 01/31/2008 | WO2008014361A2 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | WO2008014249A2 Improved preparations of 2 -substituted pyrrolo [2, 3-b] pyrazine ( 4, 7 -diazaindole ) compounds |
| 01/31/2008 | WO2008014236A1 Dimeric iap inhibitors |
| 01/31/2008 | WO2008014108A2 Antimicrobial oxazolidinone prodrugs |
| 01/31/2008 | WO2008012948A1 Methyl aquocobyrinic acid derivative, alkylation composition, and method for detoxifying harmful compound by utilizing the composition |
| 01/31/2008 | WO2008012935A1 Alkylation composition, and method for detoxification of toxic compound using the composition |
| 01/31/2008 | WO2008012635A2 Amine derivatives useful as anticancer agents |
| 01/31/2008 | WO2008012622A2 Azabenzimidazolyl compounds as potentiators of mglur2 subtype of glutamate receptor |
| 01/31/2008 | US20080027232 Reacting a dialkylboron-X where X is a leaving group with a 1-acyldipyrromethane; complex formed may be combined with a hindered alkyl amine base, such as triethylamine, diisopropylethylamine, or triphenylamine, in an organic solvent to form a solid; product may be decomplexed by contact with an OH |
| 01/31/2008 | US20080027223 Polymorphs of eszopiclone malate |
| 01/31/2008 | US20080027218 Hydroformylation Process for Pharmaceutical Intermediate |
| 01/31/2008 | US20080027102 Quinolinyl-pyrrolopyrazoles |
| 01/31/2008 | US20080027092 1-Acetic Acid-Indole, -Indazole and -Benzimidazole Derivatives Useful for the Treatment of Respiratory Disorders |
| 01/31/2008 | US20080027086 Farnesyl transferase inhibiting tricyclic quinazoline derivatives substituted with carbon-linked imidazoles or triazoles |
| 01/31/2008 | US20080027080 Cyclic derivatives as modulators of chemokine receptor activity |
| 01/31/2008 | US20080027078 9-[2-(1H-indol-3-yl)ethyl]-2-pyridin-4-yl-6,7,8,9-tetrahydro-4H-pyrimido[1,2-a]pyrimidin-4-one; glycogen synthase kinase 3 beta inhibitors; nerve growth factors; neurodegenerative diseases; Alzheimer's disease; Parkinson's disease; tauopathies; stroke; vision defects;antidiabetic agent; anticarcinogenic |
| 01/31/2008 | US20080027063 Imidazopyrazines as protein kinase inhibitors |
| 01/31/2008 | US20080027050 Heterocyclic Amide Compound and Use Thereof as an Mmp-13 Inhibitor(Amended Ex Officio) |
| 01/31/2008 | US20080027038 N-Acylated lipophilic amino acid derivatives |
| 01/31/2008 | US20080024058 OLEDs doped with phosphorescent compounds |
| 01/31/2008 | US20080023646 Photostabilisation of Fluorescent Dyes |
| 01/31/2008 | US20080022902 Process for producing dichlorodiketopyrrolopyrrole pigment of the alpha modificaton, dichlorodiketopyrrolopyrrole pigment of the alpha modification produced by the process, and coloring composition using the same |
| 01/30/2008 | EP1882686A2 Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/30/2008 | EP1881987A1 Purine derivatives and their use for treatment of autoimmune diseases |
| 01/30/2008 | EP1881986A2 Tyrosine kinase inhibitors |
| 01/30/2008 | EP1881985A2 Anhydrous crystalline forms of n-ý1-(2-ethoxyethyl)-5-(n-ethyl-n-methylamino)-7-(4-methylpyridin-2-yl-amino)-1h-pyrazolo[4,3-d]pyrimidine-3-carbonyl¨methanesulfonamide |
| 01/30/2008 | EP1881983A1 Pyrrolopyridines useful as inhibitors of protein kinase |
| 01/30/2008 | EP1881977A1 Histone deacetylase inhibitors |
| 01/30/2008 | EP1881976A1 Substituted amide derivatives as protein kinase inhibitors |
| 01/30/2008 | CN101115760A Pyrrolopyrazoles, potent kinase inhibitors |
| 01/30/2008 | CN101115756A Tetracyclic imidazo-benzodiazepines as GABA receptors modulators |
| 01/30/2008 | CN101115755A Pyrazolo-pyrimidine derivatives as MGLUR2 antagonists |
| 01/30/2008 | CN101115754A 5-alkoxyalkyl-6-alkyl-7-amino-azolopyrimidines, method for their production, their use for controlling pathogenic fungi and agents containing said substances |
| 01/30/2008 | CN101115719A Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 01/30/2008 | CN101113150A Method for synthesizing bicycle aza ring fluorescent or phosphorescent compound |
| 01/30/2008 | CN100364994C Crystal form of Peimeiqusai disodium and its preparation |
| 01/30/2008 | CN100364993C Peimequizane salt and its preparation |
| 01/29/2008 | US7323562 Method of preparing poly(ADP-ribose) polymerases inhibitors |
| 01/29/2008 | US7323484 Farnesyl transferase inhibitors |
| 01/29/2008 | US7323469 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumor |
| 01/29/2008 | US7323468 as modulators of receptor tyrosine kinases and cytoplasmic tyrosine and serine/threonine kinases; can bind both to active and also to non-active kinases and therefore influence the signal transduction |
| 01/29/2008 | US7323467 3-heteroaryl-3,5-dihydro-4-oxo-4H-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics |
| 01/29/2008 | US7323458 Dihydrobenzodiazepins and their use for treating dyslipidemia |